JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Thierry Carrel
Friedrich Eckstein
Thierry Aymard
Alexander Kadner
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carrel, T.
Right arrow Articles by Kadner, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Carrel, T.
Right arrow Articles by Kadner, A.
Related Collections
Right arrow Congenital - acyanotic
Right arrow Great vessels
Right arrow Valve disease

J Thorac Cardiovasc Surg 2008;136:472-475
© 2008 The American Association for Thoracic Surgery


Surgery for Acquired Cardiovascular Disease

Preliminary results following reinforcement of the pulmonary autograft to prevent dilatation after the Ross procedure

Thierry Carrel, MDa,*, Markus Schwerzmann, MDb, Friedrich Eckstein, MDa, Thierry Aymard, MDa, Alexander Kadner, MDa

a Clinic for Cardiovascular Surgery, University Hospital Berne, Berne, University Berne, Switzerland
b Department of Cardiology, University Hospital Berne, University Berne, Berne, Switzerland

Received for publication October 22, 2007; revisions received January 31, 2008; accepted for publication February 1, 2008.

* Address for reprints: Thierry Carrel, MD, Clinic for Cardiovascular Surgery, University Hospital, Freiburgerstrasse, 3010 Bern, Switzerland. (Email: thierry.carrel{at}insel.ch).

Objective: The Ross operation remains a controversially discussed procedure, because concern exists regarding late dilatation of the neoartic root and progressive regurgitation of the autograft valve. We present our early experience with an external reinforcement of the autograft, which is inserted into a prosthetic Dacron graft with an artificial aortic root configuration. This detail should help to prevent neoaortic root dilatation.

Patients and Methods: Between 2006 and 2007, 12 patients (mean age 16 ± 38 years; range 15–38 years) underwent a Ross procedure by this technique. Indications were aortic regurgitation (n = 2), aortic stenosis (n = 5), and combined aortic stenosis and insufficiency (n = 5). A bicuspid aortic valve was present in 9 patients. Balloon valvuloplasty had been performed in 7 patients. Follow-up was performed by clinical and echocardiographic examinations.

Results: No early or late deaths occurred in this small series, and freedom from reoperation is 100%. Echocardiographic follow-up confirmed absence of aortic insufficiency in 11 patients after a mean of 11 months (range 2–30 months). In 1 patient, a small asymmetric regurgitation jet was already observed at discharge echocardiography. As expected, no neoaortic root dilatation was observed during follow-up. All patients are in New York Heart Association class I.

Conclusions: The present technique is a simple and reproducible technical step that does not require significant additional time. Inclusion of the autograft within a root prosthesis may be especially indicated in situations known for late autograft dilatation, namely, bicuspid aortic valve, predominant aortic insufficiency, and ascending aortic enlargement.



Abbreviation and Acronym RVOT = right ventricular outflow tract








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The American Association for Thoracic Surgery.